Ignite Creation Date:
2024-05-06 @ 3:32 PM
Last Modification Date:
2025-12-16 @ 12:10 PM
Study NCT ID:
NCT04668300
Status:
None
Last Update Posted:
2025-10-09 00:00:00
First Post:
2020-08-18 00:00:00
Brief Title:
Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma
Sponsor:
MD Anderson Cancer Center
Organization:
M.D. Anderson Cancer Center
Organization Data
Organization:
M.D. Anderson Cancer Center
Class:
OTHER
Study ID:
2020-0159
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MD Anderson Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |